Clinical Trial Update: A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study of CTX-009 (ABL001) in combination with irinotecan or paclitaxel for advanced/metastatic solid tumors, including biliary tract cancer, has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CTX-009 (ABL001) (ABL001)
• Irinotecan (Irinotecan)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Handok Inc. | Conditions: P1b: Advanced Solid Tumors, P2: Biliary Tract Cancer | Phase 1, Phase 2 | Status: TERMINATED